Anal Fistula Treatment Market - Overview
Anal fistula treatment involves use of both surgical and non-surgical approaches for effective removal of anal fistulae in patients. Surgical procedures include fistulotomy, bioprosthetic plugs, advancement flap procedures, seton techniques, and new techniques such as LIFT and FiLaC therapy. Non-surgical methods include drugs as well as fibrin glue injections, adipose stem cell therapy, and collagen paste. This report analyzes the current and future prospects of the global anal fistula treatment market based on treatment type, application, end-user, and region.
This study is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the revenue of the global anal fistula treatment market in the near future. Primary research formed the bulk of the research efforts, with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation, and various international and national databases. The report provides estimated market size in US$ Mn for treatment type, application, end-user, and region for the period of 2018 to 2026.
The report contains an elaborative executive summary, which includes a snapshot providing information on various segments of the market. It also provides information and data analysis of the market with respect to segments based on treatment type, application, end-user, and region. The overview section of the report analyzes market dynamics such as drivers, restraints, and opportunities that can influence the global anal fistula treatment market in the current and future scenario. The report also provides Porter’s Five Force Analysis that studies five factors and their impact on the market.
Market share of key players is analyzed to signify the contribution of these players toward the revenue of the market. As such, these factors are likely to help market players in deciding about business strategies and plans for strengthening their position in the global market. Based on region, the market has been analyzed for five major regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. The study also covers detailed country analysis in these regions for the anal fistula treatment market.
The report also profiles major players in the global anal fistula treatment market in terms of key attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in this report include Becton, Dickinson and Company, biolitec AG, Cook Medical, Gem srl, KARL STORZ SE & Co. KG, Medtronic plc, and TiGenix NV. Inorganic growth strategies and business collaborations were the primary strategies adopted by the major players to cement their position in the global anal fistula treatment market.
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Anal Fistula Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Treatment Type Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Anal Fistula Treatment Market Analysis and Forecasts, 2016-2026
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Price Comparison Analysis (2017)
5.1.1. By Treatment Type
5.1.2. By Region
5.2.Regulatory Scenario by Region/globally
5.3.Key Mergers & Acquisitions
5.4.Disease Prevalence & Incidence Rate, by Region
5.5.Reimbursement Scenario: Anal Fistula Treatment
5.6.Technological Advancements
6. Global Anal Fistula Treatment Market Analysis and Forecasts, by Treatment Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Treatment Type, 2016-2026
6.3.1. Non-surgical
6.3.1.1. Drugs
6.3.1.2. Others
6.3.2. Surgical
6.3.2.1. Fistulotomy
6.3.2.2. Bioprosthetic Plugs
6.3.2.3. Seton Techniques
6.3.2.4. Advancement Flap Procedures
6.3.2.5. Others
6.4. Market Attractiveness, by Treatment Type
7. Global Anal Fistula Treatment Market Analysis and Forecasts, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2016-2026
7.3.1. Intersphincteric
7.3.2. Transsphincteric
7.3.3. Suprasphincteric
7.3.4. Extrasphincteric
7.3.5. Others
7.4. Market Attractiveness, by Application
8. Global Anal Fistula Treatment Market Analysis and Forecasts, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2016-2026
8.3.1. Hospitals & Ambulatory Surgical Centers
8.3.2. Clinics
8.3.3. Others
8.4. Market Attractiveness, by End-user
9. Global Anal Fistula Treatment Market Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Country/Region
10. North America Anal Fistula Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Treatment Type, 2016-2026
10.2.1. Non-surgical
10.2.1.1. Drugs
10.2.1.2. Others
10.2.2. Surgical
10.2.2.1. Fistulotomy
10.2.2.2. Bioprosthetic Plugs
10.2.2.3. Seton Techniques
10.2.2.4. Advancement Flap Procedures
10.2.2.5. Others
10.3. Market Value Forecast, by Application, 2016-2026
10.3.1. Intersphincteric
10.3.2. Transsphincteric
10.3.3. Suprasphincteric
10.3.4. Extrasphincteric
10.3.5. Others
10.4. Market Value Forecast, by End-user, 2016-2026
10.4.1. Hospitals & Ambulatory Surgical Centers
10.4.2. Clinics
10.4.3. Others
10.5. Market Value Forecast, by Country, 2016-2026
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Treatment Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Anal Fistula Treatment Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value Forecast, by Treatment Type, 2016-2026
11.2.1. Non-surgical
11.2.1.1. Drugs
11.2.1.2. Others
11.2.2. Surgical
11.2.2.1. Fistulotomy
11.2.2.2. Bioprosthetic Plugs
11.2.2.3. Seton Techniques
11.2.2.4. Advancement Flap Procedures
11.2.2.5. Others
11.3.Market Value Forecast, by Application, 2016-2026
11.3.1. Intersphincteric
11.3.2. Transsphincteric
11.3.3. Suprasphincteric
11.3.4. Extrasphincteric
11.3.5. Others
11.4.Market Value Forecast, by End-user, 2016-2026
11.4.1. Hospitals & Ambulatory Surgical Centers
11.4.2. Clinics
11.4.3. Others
11.5.Market Value Forecast, by Country/Sub-region, 2016-2026
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6.Market Attractiveness Analysis
11.6.1. By Treatment Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Anal Fistula Treatment Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value Forecast, by Treatment Type, 2016-2026
12.2.1. Non-surgical
12.2.1.1. Drugs
12.2.1.2. Others
12.2.2. Surgical
12.2.2.1. Fistulotomy
12.2.2.2. Bioprosthetic Plugs
12.2.2.3. Seton Techniques
12.2.2.4. Advancement Flap Procedures
12.2.2.5. Others
12.3.Market Value Forecast, by Application, 2016-2026
12.3.1. Intersphincteric
12.3.2. Transsphincteric
12.3.3. Suprasphincteric
12.3.4. Extrasphincteric
12.3.5. Others
12.4.Market Value Forecast, by End-user, 2016-2026
12.4.1. Hospitals & Ambulatory Surgical Centers
12.4.2. Clinics
12.4.3. Others
12.5.Market Value Forecast, by Country/Sub-region, 2016-2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6.Market Attractiveness Analysis
12.6.1. By Treatment Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Anal Fistula Treatment Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2.Market Value Forecast, by Treatment Type, 2016-2026
13.2.1. Non-surgical
13.2.1.1. Drugs
13.2.1.2. Others
13.2.2. Surgical
13.2.2.1. Fistulotomy
13.2.2.2. Bioprosthetic Plugs
13.2.2.3. Seton Techniques
13.2.2.4. Advancement Flap Procedures
13.2.2.5. Others
13.3.Market Value Forecast, by Application, 2016-2026
13.3.1. Intersphincteric
13.3.2. Transsphincteric
13.3.3. Suprasphincteric
13.3.4. Extrasphincteric
13.3.5. Others
13.4.Market Value Forecast, by End-user, 2016-2026
13.4.1. Hospitals & Ambulatory Surgical Centers
13.4.2. Clinics
13.4.3. Others
13.5.Market Value Forecast, by Country/Sub-region, 2016-2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6.Market Attractiveness Analysis
13.6.1. By Treatment Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Anal Fistula Treatment Market Analysis and Forecast
14.1.Introduction
14.1.1. Key Findings
14.2.Market Value Forecast, by Treatment Type, 2016-2026
14.2.1. Non-surgical
14.2.1.1. Drugs
14.2.1.2. Others
14.2.2. Surgical
14.2.2.1. Fistulotomy
14.2.2.2. Bioprosthetic Plugs
14.2.2.3. Seton Techniques
14.2.2.4. Advancement Flap Procedures
14.2.2.5. Others
14.3.Market Value Forecast, by Application, 2016-2026
14.3.1. Intersphincteric
14.3.2. Transsphincteric
14.3.3. Suprasphincteric
14.3.4. Extrasphincteric
14.3.5. Others
14.4.Market Value Forecast, by End-user, 2016-2026
14.4.1. Hospitals & Ambulatory Surgical Centers
14.4.2. Clinics
14.4.3. Others
14.5.Market Value Forecast, by Country/Sub-region, 2016-2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6.Market Attractiveness Analysis
14.6.1. By Treatment Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1.Market Footprint Analysis
15.1.1. By Region
15.1.2. By Treatment Type
15.2. Competitive Business Strategies
15.3. Company Profiles
15.3.1. Becton, Dickinson and Company
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Business Overview
15.3.1.3. Product Portfolio
15.3.1.4. Financial Overview
15.3.1.5. SWOT Analysis
15.3.1.6. Strategic Overview
15.3.2. biolitec AG
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Business Overview
15.3.2.3. Product Portfolio
15.3.2.4. Financial Overview
15.3.2.5. SWOT Analysis
15.3.2.6. Strategic Overview
15.3.3. Cook Medical
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Business Overview
15.3.3.3. Product Portfolio
15.3.3.4. Financial Overview
15.3.3.5. SWOT Analysis
15.3.3.6. Strategic Overview
15.3.4. Gem srl
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Business Overview
15.3.4.3. Product Portfolio
15.3.4.4. Financial Overview
15.3.4.5. SWOT Analysis
15.3.4.6. Strategic Overview
15.3.5. KARL STORZ SE & Co. KG
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Business Overview
15.3.5.3. Product Portfolio
15.3.5.4. Financial Overview
15.3.5.5. SWOT Analysis
15.3.5.6. Strategic Overview
15.3.6. Medtronic plc
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Business Overview
15.3.6.3. Product Portfolio
15.3.6.4. Financial Overview
15.3.6.5. SWOT Analysis
15.3.6.6. Strategic Overview
15.3.6. TiGenix NV
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Business Overview
15.3.6.3. Product Portfolio
15.3.6.4. Financial Overview
15.3.6.5. SWOT Analysis
15.3.6.6. Strategic Overview
15.3.6. W. L. Gore & Associates, Inc. (Gore Medical)
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Business Overview
15.3.6.3. Product Portfolio
15.3.6.4. Financial Overview
15.3.6.5. SWOT Analysis
15.3.6.6. Strategic Overview
